Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Jeffrey A Towbin

Biographic Data

ID6649944
NAMEJeffrey A Towbin
GIVEN NAMESJeffrey A
FAMILY NAMETowbin
SIGNATURETOWBIN J A
AFFILIATIONSLe Bonheur Children's Hospital
ORCID0000-0002-4182-2786
VERIFIEDYes
TOTAL WORKS14
TOTAL CITATIONS0
AUTHOR COUNT14
EDITOR COUNT0
FIRST PUBLICATION YEAR2012
LATEST PUBLICATION YEAR2023
H-INDEX0
  • Elevated Copeptin Levels Are Associated with Heart Failure Severity and Adverse Outcomes in Children with Cardiomyopathy

    Open Access•Karan Karki, Karan B Karki et al.•ARTICLE•Children•2023

    In children with cardiomyopathy, the severity of heart failure (HF) varies. However, copeptin, which is a biomarker of neurohormonal adaptation in heart failure, has not been studied in these patients. In this study, we evaluated the correlation of copeptin level with functional HF grading, B-type natriuretic peptide (BNP), and echocardiography variables in children with cardiomyopathy. Furthermore, we determined if copeptin levels are associated…

  • Feasibility and Safety of Percutaneous Cardiac Interventions for Congenital and Acquired Heart Defects in Infants ≤1000 g

    Open Access•Ranjit Philip, Jeffrey A Towbin et al.•ARTICLE•Children•2021

    The transcatheter closure of patent ductus arteriosus (TCPC) has been demonstrated to be feasible even in infants weighing ≤1000 g. However, other percutaneous cardiac interventions (PCI) for such small infants born with congenital heart defects (CHD) or acquired heart defects (AHD) have not been well described. The purpose of this study was to describe the feasibility and safety of PCI in infants ≤1000 g. A retrospective review was conducted bet…

  • Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017

    Open Access•Daniel Dicker, Grant Nguyen et al.•ARTICLE•The Lancet•2018

    BACKGROUND: Assessments of age-specific mortality and life expectancy have been done by the UN Population Division, Department of Economics and Social Affairs (UNPOP), the United States Census Bureau, WHO, and as part of previous iterations of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD). Previous iterations of the GBD used population estimates from UNPOP, which were not derived in a way that was internally consistent wit…

  • Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017

    Open Access•Jeffrey D Stanaway, Ashkan Afshin et al.•ARTICLE•The Lancet•2018

    BackgroundThe Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 comparative risk assessment (CRA) is a comprehensive approach to risk factor quantification that offers a useful tool for synthesising evidence on risks and risk–outcome associations. With each annual GBD study, we update the GBD CRA to incorporate improved methods, new risks and risk–outcome pairs, and new data on risk exposure levels and risk–outcome associatio…

  • Global, regional, and national disability-adjusted life-years (Dalys) for 359 diseases and injuries and healthy life expectancy (Hale) for 195 countries and territories, 1990–2017

    Open Access•Hmwe Hmwe Kyu, D Abate et al.•ARTICLE•The Lancet•2018

    BACKGROUND: How long one lives, how many years of life are spent in good and poor health, and how the population's state of health and leading causes of disability change over time all have implications for policy, planning, and provision of services. We comparatively assessed the patterns and trends of healthy life expectancy (HALE), which quantifies the number of years of life expected to be lived in good health, and the complementary measure o…

  • Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories

    Open Access•R Lozano, Nancy Fullman et al.•ARTICLE•The Lancet•2018

    BACKGROUND: Efforts to establish the 2015 baseline and monitor early implementation of the UN Sustainable Development Goals (SDGs) highlight both great potential for and threats to improving health by 2030. To fully deliver on the SDG aim of "leaving no one behind", it is increasingly important to examine the health-related SDGs beyond national-level estimates. As part of the Global Burden of Diseases, Injuries, and Risk Factors Study 2017 (GBD 2…

  • Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017

    Open Access•L James, Spencer L James et al.•ARTICLE•The Lancet•2018

    BACKGROUND: The Global Burden of Diseases, Injuries, and Risk Factors Study 2017 (GBD 2017) includes a comprehensive assessment of incidence, prevalence, and years lived with disability (YLDs) for 354 causes in 195 countries and territories from 1990 to 2017. Previous GBD studies have shown how the decline of mortality rates from 1990 to 2016 has led to an increase in life expectancy, an ageing global population, and an expansion of the non-fatal…

  • Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013

    Open Access•Mohammad H Forouzanfar, Lily Alexander et al.•ARTICLE•The Lancet•2015

  • Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013

    Open Access•Theo Vos, Ryan M Barber et al.•ARTICLE•The Lancet•2015

  • Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013

    Open Access•Christopher J L Murray, Katrina F Ortblad et al.•ARTICLE•The Lancet•2014

  • Global, regional, and national levels and causes of maternal mortality during 1990–2013

    Open Access•Nicholas J Kassebaum, Amelia Bertozzi-Villa et al.•ARTICLE•The Lancet•2014

  • Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010

    Open Access•Theo Vos, Abraham D Flaxman et al.•ARTICLE•The Lancet•2012

  • Disability-adjusted life years (Dalys) for 291 diseases and injuries in 21 regions, 1990–2010

    Open Access•Christopher J L Murray, Theo Vos et al.•ARTICLE•The Lancet•2012

  • Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010

    Open Access•R Lozano, Mohsen Naghavi et al.•ARTICLE•The Lancet•2012

No prominent works on this page.

  • Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010

    Open Access•Theo Vos, Abraham D Flaxman et al.•ARTICLE•The Lancet•2012

  • Disability-adjusted life years (Dalys) for 291 diseases and injuries in 21 regions, 1990–2010

    Open Access•Christopher J L Murray, Theo Vos et al.•ARTICLE•The Lancet•2012

  • Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010

    Open Access•R Lozano, Mohsen Naghavi et al.•ARTICLE•The Lancet•2012

  • Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013

    Open Access•Christopher J L Murray, Katrina F Ortblad et al.•ARTICLE•The Lancet•2014

  • Global, regional, and national levels and causes of maternal mortality during 1990–2013

    Open Access•Nicholas J Kassebaum, Amelia Bertozzi-Villa et al.•ARTICLE•The Lancet•2014

  • Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013

    Open Access•Mohammad H Forouzanfar, Lily Alexander et al.•ARTICLE•The Lancet•2015

  • Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013

    Open Access•Theo Vos, Ryan M Barber et al.•ARTICLE•The Lancet•2015

  • Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017

    Open Access•Daniel Dicker, Grant Nguyen et al.•ARTICLE•The Lancet•2018

    BACKGROUND: Assessments of age-specific mortality and life expectancy have been done by the UN Population Division, Department of Economics and Social Affairs (UNPOP), the United States Census Bureau, WHO, and as part of previous iterations of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD). Previous iterations of the GBD used population estimates from UNPOP, which were not derived in a way that was internally consistent wit…

  • Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017

    Open Access•Jeffrey D Stanaway, Ashkan Afshin et al.•ARTICLE•The Lancet•2018

    BackgroundThe Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 comparative risk assessment (CRA) is a comprehensive approach to risk factor quantification that offers a useful tool for synthesising evidence on risks and risk–outcome associations. With each annual GBD study, we update the GBD CRA to incorporate improved methods, new risks and risk–outcome pairs, and new data on risk exposure levels and risk–outcome associatio…

  • Global, regional, and national disability-adjusted life-years (Dalys) for 359 diseases and injuries and healthy life expectancy (Hale) for 195 countries and territories, 1990–2017

    Open Access•Hmwe Hmwe Kyu, D Abate et al.•ARTICLE•The Lancet•2018

    BACKGROUND: How long one lives, how many years of life are spent in good and poor health, and how the population's state of health and leading causes of disability change over time all have implications for policy, planning, and provision of services. We comparatively assessed the patterns and trends of healthy life expectancy (HALE), which quantifies the number of years of life expected to be lived in good health, and the complementary measure o…

  • Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories

    Open Access•R Lozano, Nancy Fullman et al.•ARTICLE•The Lancet•2018

    BACKGROUND: Efforts to establish the 2015 baseline and monitor early implementation of the UN Sustainable Development Goals (SDGs) highlight both great potential for and threats to improving health by 2030. To fully deliver on the SDG aim of "leaving no one behind", it is increasingly important to examine the health-related SDGs beyond national-level estimates. As part of the Global Burden of Diseases, Injuries, and Risk Factors Study 2017 (GBD 2…

  • Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017

    Open Access•L James, Spencer L James et al.•ARTICLE•The Lancet•2018

    BACKGROUND: The Global Burden of Diseases, Injuries, and Risk Factors Study 2017 (GBD 2017) includes a comprehensive assessment of incidence, prevalence, and years lived with disability (YLDs) for 354 causes in 195 countries and territories from 1990 to 2017. Previous GBD studies have shown how the decline of mortality rates from 1990 to 2016 has led to an increase in life expectancy, an ageing global population, and an expansion of the non-fatal…

  • Feasibility and Safety of Percutaneous Cardiac Interventions for Congenital and Acquired Heart Defects in Infants ≤1000 g

    Open Access•Ranjit Philip, Jeffrey A Towbin et al.•ARTICLE•Children•2021

    The transcatheter closure of patent ductus arteriosus (TCPC) has been demonstrated to be feasible even in infants weighing ≤1000 g. However, other percutaneous cardiac interventions (PCI) for such small infants born with congenital heart defects (CHD) or acquired heart defects (AHD) have not been well described. The purpose of this study was to describe the feasibility and safety of PCI in infants ≤1000 g. A retrospective review was conducted bet…

  • Elevated Copeptin Levels Are Associated with Heart Failure Severity and Adverse Outcomes in Children with Cardiomyopathy

    Open Access•Karan Karki, Karan B Karki et al.•ARTICLE•Children•2023

    In children with cardiomyopathy, the severity of heart failure (HF) varies. However, copeptin, which is a biomarker of neurohormonal adaptation in heart failure, has not been studied in these patients. In this study, we evaluated the correlation of copeptin level with functional HF grading, B-type natriuretic peptide (BNP), and echocardiography variables in children with cardiomyopathy. Furthermore, we determined if copeptin levels are associated…

Medicine (12 works) · Environmental health (10 works) · Demography (8 works) · Population (7 works) · Health disparities and outcomes (6 works) · Burden of disease (5 works) · Disease (5 works) · Global health (5 works) · Global Maternal and Child Health (5 works) · Disease burden (4 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae